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A long-standing debate in the Cu-O2 field has revolved around the relevance of the Cu(III)
oxidation state in biological redox processes. The proposal of Cu(III) in biology is generally
challenged as no spectroscopic or structural evidence exists currently for its presence. The reaction
of synthetic Cu(I) complexes with O2 at low temperature in aprotic solvents provides the
opportunity to investigate and define the chemical landscape of Cu-O2 species at a small molecule
level of detail; eight different types are characterized structurally, three of which contain at least
one Cu(III) center. Simple imidazole or histamine ligands are competent in these oxygenation
reactions to form Cu(III) complexes. The combination of synthetic structural and reactivity data
suggests (i) that Cu(I) should be considered as either a one or two electron reductant reacting with
O2, (ii) that Cu(III) reduction potentials of these formed complexes are modest and well within the
limits of a protein matrix and (iii) that primary amine and imidazole ligands are surprisingly good
at stabilizing Cu(III) centers. These Cu(III) complexes are efficient oxidants for hydroxylating
phenolate substrates with reaction hallmarks similar to that performed in biological systems. The
remarkable ligation similarity of the synthetic and biological systems makes it difficult to continue
to exclude Cu(III) from biological discussions.

Biology & Cu-O2

Author Manuscript

Copper (Cu) is one the most frequently used metals in enzymes to activate dioxygen (O2)
and the mushroom Cu enzyme Tyrosinase (Ty) provided the first example in 1955 of direct
integration of an oxygen-atom from O2 into an organic product by an enzyme [1]. Given the
diverse oxidative function of these enzymes, many different assemblies have evolved.
Mononuclear to trinuclear copper active sites that activate O2 are now known, which are
capable of oxidase transformations (e.g. alcohols to aldehydes), monooxygenase
transformations (e.g. alkanes to alcohols), and full reduction of O2 to water [2–4]. Each
enzyme is tuned remarkably to perform its specific reaction by exploiting the oxidizing
power of O2 [4]. It is the controlled and efficient nature of these oxidative processes with O2
that has captured the attention of the synthetic community with a vision of selective Cu-O2
catalysts, using an earth-abundant metal and the most prevalent oxidant on the planet.
Copper in biology is considered currently to be a one electron reservoir shuttling between
the Cu(I) and Cu(II) oxidation states, whether mediating an electron transfer (ET) process or
activating O2 in an enzyme to oxidize a substrate. In the past two decades, it has become
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clear from synthetic systems with ligation similar, if not identical, to the biological sites that
Cu(I) complexes react with O2 to yield not only Cu(II) but also Cu(III) species – Cu(III)-O2
species are thermodynamically stable relative to their Cu(I) and O2 starting materials. Yet,
even with their characteristic Cu(III) spectroscopic signatures, no experimental evidence
exists currently for its role in biology.

Author Manuscript

The scope of this review focuses on spectroscopically or structurally characterized highvalent Cu-O2 complexes (i.e., Cu(III)) formed in the homogeneous reaction of Cu(I) with O2
with nitrogen and oxygen ligation, and their subsequent reactivity with exogenous
substrates. This review will concentrate primarily on cases where definitive spectroscopic
and structural characterization of Cu(III) exist, though systems exhibiting reactivity
hallmarks of Cu(III) species and lacking spectroscopic detection will be introduced, as
interconverting valence isomers may be operative. While intramolecular ligand oxidation by
these species defines reactivity possibilities, this review concentrates on intermolecular
substrate reactivities, which, in the opinion of the reviewers, provide greater insights into
development of useful stoichiometric or catalytic oxidants derived from O2. Furthermore,
catalytic Cu-O2 systems for organic oxidations have been reported [5–8], but the
involvement of Cu(III)-O2 intermediates is unknown.
Structural Types of Cu-O2 Species

Author Manuscript

The pursuit of the types of Cu-O2 species that can be formed in the reaction of simple Cu(I)
complexes and O2 has fascinated synthetic and mechanistic chemists for more than seventy
years. Their ligation lability and oxidative power confound this research, which has trended
to low temperatures (−80 °C to −145 °C) to stabilize the complexes. The resulting structural
diversity is remarkable, with 1:1 to 3:1 Cu:O2 stoichiometries, including several isomers
within a given stoichiometry. Currently, eight different Cu-O2 types have been characterized
structurally from the reaction of Cu(I) and O2: η1-end-on Cu(II) superoxide ES (2006) [9],
η2-side-on Cu(II) superoxide SS (1994) [10], η2-side-on Cu(III) peroxide MP (2002)
[11,12], dimeric cis-μ-η1:η1 Cu(II) peroxide CP (2014) [13], dimeric trans-η-1,2 Cu(II)
peroxide TP (1988) [14], dimeric μ-η2:η2-side-on Cu(II) peroxide SP (1989) [15], dimeric
Cu(III) bis-μ2-oxide O (1996) [16], and trinuclear Cu(III)Cu(II)Cu(II) bis-μ3-oxide T (1996)
[17] (Fig. 1). Three of the eight types contain a Cu(III) center derived from the reaction of
Cu(I) and O2.

Author Manuscript

This structural diversity is associated with copper nuclearity and the reduced O2 binding
mode. The stoichiometries of these complexes are determined primarily by ligand steric
demands and ligand denticity, which is succinctly summarized through a ligand steric
continuum [19] (Fig. 1). The most sterically demanding ligands, which effectively preclude
copper dimerization, yield mononuclear superoxide or peroxide species, with the superoxide
ligated either in a side-on (ES) or end-on fashion (SS) [20]. Less demanding ligands, if
tetradentate, preferentially stabilize a TP species (Cu-Cu, ca. 4.4 Å) or a CP species (Cu-Cu,
ca. 3.8 Å), if the ligand enforces a cis geometry. Tri- or bi-dentate ligands collapse to SP
species (Cu-Cu, ca. 3.5 Å) or a Cu(III)-containing O species (Cu-Cu, ca. 2.8 Å). Bidentate
amine ligands (e.g., diamines, histamines, pyridylamines) almost exclusively form O
species, which constitute the largest family of synthetic Cu-O2 species to date [19,21,22].
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Finally, the least sterically demanding bidentate ligands (e.g., primary amines, methylated
amines, histamines) form the most compact Cu-O2 core, a trinuclear T cluster (Cu-Cu ca.
2.7 Å) [2,23]. Ligands that support the Cu(III) species of interest for this review are shown
in Fig. 2.

Author Manuscript

While ligand steric demands are a dominant force in determining the Cu-O2 binding mode,
the nature of the ligating groups and the Cu(I) geometry are also important. Strongly
donating, basic amines or anionic nitrogen donors not only stabilize the contracted Cu(III)
center but also create more reducing Cu(I) precursor complexes, facilitating their reaction
with O2 [2,24]. If a productive reaction is to occur, the Cu(I) precursor must provide innersphere binding access for O2 to allow association and ET; Cu(I) complexes in a tetrahedral
geometry are typically not reactive with O2. Three-coordinate trigonal or T-shape complexes
or four-coordinate trigonal monopyramidal geometries are generally the most reactive Cu(I)
precursor geometries, as O2, an impotent ligand, is not required to compete with a weakly
associating solvent or counteranion.

Spectroscopic Characterization
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The spectroscopic and metrical parameters for the eight structurally characterized Cu-O2
species are surprisingly distinct, which allows for solution characterization by a combination
of optical, vibrational, and x-ray absorption spectroscopies (XAS). The reaction of d10 Cu(I)
complexes with O2 generally lead to significant changes in the optical spectra with the
appearance of intense ligand to metal charge transfer (LMCT) bands, generally characterized
as oxygen to copper charge transfers. The optical comparison in Fig 3. of the three most
common 2:1 species (TP, SP, O) effectively allows for their unambiguous characterization,
assuming full formation of a single Cu-O2 species. Redox titrations with weak H-atom
donors such as ascorbic acid or carboxyferrocene provide critical insights into formation
yields [21,23,25]. Of course, the energies of the LMCT bands are sensitive to the nature of
the ligand, but the optical features are generally consistent. Recent studies on O and T
species with varied amine and imidazole ligation correlate more donating ligation to a
systematic blue-shifting of the LMCT optical bands for complexes of the same structural
type [21,22]. As many of these complexes are thermally sensitive and can exist as an
equilibrium of isomers in solution (vide infra), resonance Raman (rR) is generally preferred
over infrared spectroscopic characterization, as the former enables optical and vibrational
correlations [26–28]. A superoxide stretching frequency (960–1130 cm−1) [4] is
distinguished readily from that of a peroxide (720–960 cm−1) [2,24,13] or that of the bisoxide core (590–620 cm−1) [29,30]. The combination of optical and rR spectroscopy is
extremely powerful for distinguishing among these species. Solution Cu K-edge XAS is also
a valuable tool to differentiate between the SP (Cu-Cu, ca. 3.6 Å), O (ca. 2.8 Å), and T (ca.
2.7 Å) species through their Cu-Cu separations; acceptable fits to their Extended X-ray
Absorption Fine Structure (EXAFS) require a Cu-Cu scattering distance that is effectively
invariant among all model fits for a single complex. The copper pre-edge feature of these
absorptions, albeit weak, also has characteristic oxidation information encoded in their
energies, with Cu(I) absorbing at 8984 ± 1 eV, Cu(II) at 8979 ± 0.5 eV, and Cu(III) at 8981
± 0.5 eV [31,32]. The intensity of Cu(II) and Cu(III) features generally increase with
distortion from a planar coordination geometry [33]. However, the Cu(II) pre-edge intensity
J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
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is usually more intense than that of Cu(III) for a given ligation environment. Consequently,
the pre-edge of a T complex, composed of two-thirds Cu(II) and one-third Cu(III), only
reveals Cu(II) features; the higher energy feature associated with Cu(III) is obscured by the
Cu(II) pre-edge absorption along with the rising edge [33].

General Reactivity

Author Manuscript

Beyond the wealth of spectroscopic and structural data provided by these synthetic
complexes, detailed mechanistic studies provide insights into their reactivity tendencies with
external substrates. The oxidative reactivity of these reagents can vary from electrophilic to
nucleophilic. Generally, the superoxide species are limited in their oxidizing abilities; if
reactivity is observed, it is usually only with weak O-H and C-H bonds [34]. Reactivity
characterization of the CP species is incomplete currently as reactivity with weak C-H bonds
is only observed upon warming, leaving the possibility of forming a different active species
upon decomposition [13]. The end-on peroxide of TP has nucleophilic character, as it is
protonated readily, does not oxidize PPh3, and oxidizes benzaldehyde to benzoic acid
[35,36]. By contrast, the side-on peroxide of SP, while susceptible to protonation by acid
[35,37,38], is capable of PPh3 oxidation and can oxidize phenolates to catechols and
catechols to quinones through an electrophilic mechanism [34,37]. The O species are the
most potent oxidants, capable of phenolate hydroxylation, C-F activation, and C-H
activation [2,18,25,39–41]. The extremely compact nature of the T species precludes most
reactivity, with the exceptions of proton-coupled electron transfer (PCET) from weak O-H
substrates and oxidation of PPh3 [23,42–44].

Cu(III) Geometric Preferences and Redox Potentials
Author Manuscript
Author Manuscript

Cu(III) has been excluded generally from biological discussions, as the positive reduction
potentials of most mononuclear Cu(III) complexes are significantly above 1 V vs NHE,
which would lead to oxidation of proximal protein residues. The highest reported reversible
copper potential is that of the blue copper site of fungal laccases, a Cu(II)/(I) process, at ca.
0.8 V [45]. By comparison, the reduction of [Cu(III)(cyclam)]3+ occurs above 1.5 V, with a
macrocyclic tetraamine ligand almost ideally suited to match the planar coordination
preference of a d8 Cu(III) center [46]. However, the addition of anionic ligation significantly
attenuates the positive reduction potentials. The Margerum group demonstrated clearly that
monomeric Cu(III)/Cu(II) potentials can be moved within the biological range by including
strong anionic ligation in a planar coordination geometry: a triply deprotonated glycine
tripeptide Cu(III) complex with two amidate ligands has a potential in water near 0.9 V, and
even more donating ligands lower the reduction potentials to near 0.4 V [47,48]. This
principle is further demonstrated by a dianionic pyridinedicarboxamide ligand in
conjunction with a ligated hydroxide that creates a neutrally charged Cu(III) species with a
reduction potential of ca. 0.7 V [49,50], which is reactive with moderately strong C-H
bonds. Though deprotonated amide ligands are now reported to ligate Fe, Co, and Ni centers
in enzymes [51–54], no such ligation is known currently for any copper enzymes. The redox
potentials of a variety of mononuclear Cu complexes with neutral to trianionic ligands,
presented by the Krüger group [55], clearly show a correlation of anionic ligation to lower
Cu(III) reduction potentials (Fig. 4). Copper centers that react with O2 have an advantage in
J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
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stabilizing Cu(III), as the reduced O2 species generate anionic ligation. In the extreme of
four electron reduction of O2, two dianionic oxide ligands are formed possessing the ability
to bind the copper centers in a planar geometry, thereby stabilizing the Cu(III) oxidation
state. This analysis suggests that if Cu(III) plays a mechanistic role in a copper, O2activating enzyme, the bi- and trinuclear sites would be foremost candidates.

Mononuclear Cu(III) Examples

Author Manuscript

Examples of mononuclear Cu-O2 species are less common than their multinuclear
counterparts presumably due to their tendency to dimerize rapidly in homogenous solutions.
This transient existence often confounds their characterization. While several examples of
mononuclear Cu(II)-superoxide complexes exist [9,56–58,20], only a single example of a
mononuclear, Cu(III)-peroxide, MP, is known: the Cu(I) complex of a sterically demanding
β-diketiminate (Dk) ligand directly oxygenates to a mononuclear Cu-O2 species [11]. X-ray
crystallography reveals short Cu-O/N distances of ca. 1.8 Å with an O-O separation of ca.
1.4 Å, consistent with a peroxide level O2 species [12]. Spectroscopic studies of three MP
derivatives show rR O-O vibrations in the 750–930 cm−1 range and a pre-edge Cu K-edge
XAS feature at 8981 eV, both of which support a Cu(III) peroxide description [24]. This
contrasts with the reaction of O2 with sterically bulky tris-pyrazolylborate Cu(I) complexes,
an overall neutral complex similar to Cu(I)-Dk, that yields a side-on Cu(II)-superoxide
species, SS [10].

Author Manuscript

Despite the tendency of Cu(III) complexes to be avid oxidants, the MP complexes exhibit
limited reactivity with exogenous substrates; no reaction is reported with weak O-H or C-H
substrates, and PPh3 displaces the bonded O2 to yield a Cu(I)-PPh3 complex, suggesting
weak nucleophilic activity. Density functional theory (DFT) calculations indicate that these
Cu(III)-peroxides possess modest reduction potentials and are weakly basic upon reduction,
supporting the limited PCET abilities. This stabilized Cu(III) center presumably results from
the strong anionic donation from the Dk ligand. While this sterically demanding anionic
ligation promotes the reactivity of the ligated Cu(I) with O2 and prevents dimerization, its
stabilizing effect attenuates reactivity [24,59].

Binuclear Cu(III) Examples

Author Manuscript

The reduction of O2 to a peroxide or oxide level is more thermodynamically favorable than
to a superoxide level, and four different 2:1 Cu:O2 isomers are known currently (i.e., TP, CP,
SP, O) [2,60]. The distinct spectroscopy of each isomer is consistent with their strikingly
different metrical parameters and substrate reactivity (Fig. 3). While the reactivity of the CP
species has not been extensively explored [13], the end-on peroxide of the TP species
primarily reacts as a nucleophilic oxidant [36], and the SP [61] and O [18,62] species react
as electrophilic oxidants. The O species are of particular interest because of their varied
substrate scope. While attributing a reactivity to a specific structural type is convenient,
active oxidant identification can be complicated by the existence of facile equilibria among
the 2:1 species (vide infra) [16,28,38,63,64].

J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
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O Species Discovery
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The O species, initially observed in 1993 [65], was characterized in 1995 by the Tolman
group using a sterically demanding triazacyclononane ligand; oxygenation of
[(Bn3TACN)Cu(I)(MeCN)]+ at −80 °C produced distinct optical features, rR vibrations, and
Cu-Cu distance from Cu K-edge XAS [66]. The short Cu-Cu distance (ca. 2.8 Å) was
consistent with high-valent copper centers, though initially assigned as a bis-Cu(II)-bis-oxyl
formulation from calculations. Subsequent crystallographic characterization confirmed Cu-O
distances (ca. 1.8 Å) much shorter than previously observed for Cu(II) complexes [16]. The
facial-capping trinitrogen ligation of each TACN ligand flexes to allow two short Cu-N
distances (ca. 2.0 Å) in the plane defined by the Cu2O2N4 atoms and one long axial Cu-N
distance (ca. 2.3 Å) creating a coordination environment suitable for Cu(III). Each copper
center provides two electrons to fully reduce O2, forming two anionic oxide ligands.
Intermolecular reactivity of this complex and the related iPr3TACN complex is limited given
the large steric demands of the ligands. However, intramolecular dealkylation of N-alkyl
ligand substituents, a two electron, two proton process, is observed upon thermal decay
[16,67].

Author Manuscript

Most O species are thermally sensitive, and most investigations have been performed at
−80 °C to −145 °C. The thermal decay is usually associated with ligand oxidation; in the
case of N-alkyl substituents, the weakest C-H(D) bond is removed in a unimolecular rate
limiting step upon warming, as evidenced by a large primary kinetic isotope effect (KIE)
with deuterium substitution [68–70]. Formation of a carbinolamine intermediate is proposed
generally, which subsequently decomposes to an aldehyde or ketone product and dealkylated
amine. A O species can also thermally decay through oxidation of ligand aryl substituent to
yield a phenolate through a direct, electrophilic oxygen-atom transfer [71,72]. These
intramolecular oxidations demonstrate that the Cu2O2 O core can be reactive to either alkyl
or aryl C-H bonds. Numerous examples of O species are now characterized to be stabilized
by peralkylated diamines [19,21], triamines [16,73], and hybrid ligands containing alkylated
amines combined with aromatic nitrogen or guanidyl groups [22,72,74]. Bidentate ligation
provides a coordination environment that best matches the planar preference of a Cu(III)
center with the added benefit of providing axial access of substrates to the Cu2O2 core [75].

O and SP Equilibrium

Author Manuscript

Oxygenation of [(iPr3TACN)Cu(I)(MeCN)]+ at −80 °C under specific conditions yields a
remarkable finding by the Tolman group of an equilibrium of two structural types, O and SP
isomers, in optically-measurable amounts. This isomeric interconversion involves the
forming and breaking of the O-O bond with concurrent reduction and oxidation of the
Cu(III) and Cu(II) centers, respectively [16,76]. Oxygenation of the more sterically
demanding [(tBu3TACN)Cu(I)(MeCN)]+ yields exclusively a SP species [73,77]. Thus, the
variation of the alkyl substituents on the TACN ligand backbone from Me [78] to tBu [73]
generates optically pure O to SP species, respectively, illustrating a ligand steric continuum
resulting in a Cu-O2 speciation change. The variation of Cu-O2 structural type with variation
of alkyl substituents is even more extreme with bidentate, nitrogenous ligands as SP, O, and
T species can all be formed as clearly demonstrated by the Stack and Itoh groups [19].

J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
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The potential energy surface (PES) of the O ↔ SP equilibrium can be relatively flat
depending on the ligand choice, such that speciation is affected by many subtle variables
including solvent, temperature, and counteranion. In the cases where measured, the O
species is favored enthalpically (i.e., the equilibrium is biased to the O species at lower
temperatures), while SP species are favored entropically [26,63,79]. More significant
changes, such as axial coordination of a bridging ligand or addition of a more coordinating
anion, can trigger isomerization of a O isomer to its corresponding SP species, as
demonstrated with the bidentate ligand TEPD (N,N,N’,N’-tetraethylpropylenediamine) [79].
Such valence isomerization equilibria has now been extended by the Karlin group to include
TP and O species, and calibrated DFT calculations support a relatively flat PES among three
2:1 Cu:O2 isomers [28].

Author Manuscript

Optically characterized O species are known to react with an array of externally added
substrates including weak O-H, S-H, and C-H bonds, such as ascorbic acid derivatives,
phenols, catechols, thiols, alkylated amines, and hydroxylamines at low temperatures. In
most cases, these reactions result in formation of Cu(II)-hydroxide products, which are the
thermodynamic products of this chemistry. This suggests that the O species is ideally suited
for two proton, two electron oxidations. The O complexes can also act as an oxygen-atom
transfer reagent for reactive, exogenous substrates such as PPh3 [63]. Understanding the
factors that control this diverse exogenous reactivity is important for dissecting reactivity in
biological systems and development of selective chemical oxidants.

Oxidase Reactivity of O Species with External Substrates

Author Manuscript
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Significant insights into the exogenous substrate reactivity of the O species initially came in
1999 from the stoichiometric oxidation of alcohols to yield carbonyl products [70].
Screening greater than ten different O species ligated by alkylated diamines identified
OTMPD (TMPD = N,N,N’,N’-tetramethylpropylenediamine) as the most reactive of the
group [69]. The small methyl substituents of TMPD are beneficial, allowing for substrate
access to the Cu2O2 core. Additionally, the relatively strong N-methyl C-H bonds generate a
more stable O species, as the N-dealkylation pathway is attenuated significantly; more than
90% of the intact ligand is recovered upon thermal decomposition [69]. OTMPD is
indefinitely stable at −80 °C and sufficiently stable for reactivity studies at −40 °C. OTMPD
reacts with alkyl and benzylic alcohols stoichiometrically to produce aldehyde or ketone
products in yields of 60–90% based on oxidant using two equivalents of alcohol per OTMPD.
The isolated yields can be improved with additional equivalents of OTMPD as subsequent
oxidation of product is not observed. Stoichiometric addition of Et3N greatly enhances the
rate of alcohol oxidation, allowing the reaction to be performed at −80 °C in less than three
hours with a dramatic increase in selectivity for primary over secondary alcohols.
The rate limiting step does not involve the Cα-H bond cleavage, as the rates of PhCH2OH
and PhCD2OH oxidation at −40 °C are effectively identical, but the product determining
step (PDS) does involve Cα-H(D) bond cleavage as evidenced by an intramolecular KIE of
5 for PhCHDOH [70,80]. The lithium salt of PhCHDOH reacts on mixing at −80 °C with a
similar KIE of 5, suggesting that alcohol and alkoxide oxidation occurs through the same
PDS. Combined, these data suggest a mechanism in which the alcohol binds to OTMPD and,
J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
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upon deprotonation, rearrangement positions the alkoxide within the equatorial plane of the
Cu2O2 O core enabling C-H activation and substrate oxidation. The amine ligand must be
sufficiently flexible to allow for this rearrangement, an attribute of the 6-membered TMPD
chelate. The four electron oxidation of primary amines to nitriles also occurs using two
equivalents of OTMPD at −80 °C through the intermediacy of an imine. As with alcohol
substrates, a significant primary over secondary amine selectivity exists, supporting an initial
binding to the Cu2O2 core. However, OTMPD does not react in any appreciable way with the
weak C-H bonds of 1,4-cyclohexanediene (CHD) or dihydroanthracene (DHA) at −80 °C
over a three-hour period. Beyond performing near-quantitative oxidation of weak O-H and
S-H substrates (e.g., phenols to phenoxyl radicals or bis-phenols; catechols to quinones;
thiols to disulfides) through either a sequential electron, proton transfer (ETPT) or concerted
PCET mechanism, an oxygen atom of OTMPD can be transferred to an exogenous substrate,
initially demonstrated with PPh3, under purged O2 conditions [63]. This detailed reactivity
scope clearly demonstrates the oxidizing proclivity of the Cu2O2 O core and the importance
of substrate access to the copper centers.

C-H Oxidase Reactivity of O Species with External Substrates

Author Manuscript

In 2001, the Fukuzumi and Itoh groups reported the first example of a O species that reacts
with exogenous substrates containing weak C-H bonds, such as N-methyl-9,10dihydroacridine (AcrH2) and CHD to yield N-methylacridinium ion and benzene,
respectively [81]. Curiously, this oxidase reactivity is second order with respect to the O
species with C-H bond cleavage as rate limiting. Prior work from this group reported that a
closely related bidentate ligand with appended benzylic C-H groups exhibited intramolecular
monooxygenase reactivity [72,82]. Intermolecular monooxygenase activity on aliphatic C-H
substrates is still not documented for an O species.

Author Manuscript

Despite the wealth of structural, spectroscopic, and reactivity data from O species, their
biological significance is generally excluded given the absence of any known characteristic
spectroscopic signature of Cu(III) from a biological system in conjunction with limited use
of biologically relevant ligands in the synthetic investigations [4,83]. Oxygenation of Cu(I)histamine, Cu(I)-alkylhistamine or Cu(I)-imidazole complexes do not yield spectra
consistent with a pure O species even at −145 °C [23,39]. A pure O species with imidazole
ligation, only disclosed in 2014, requires an indirect, synthetic pathway through a ligand
exchange reaction with a preformed O species at −125 °C [22,84]. Two equivalents of Nτbutylhistamine (Nτ ≡ Nε), Nτ,N,N-trimethylhistamine (HIS), or even propylenediamine
(PD) displace the TMPD ligands from OTMPD at −125 °C to generate new O species that
contain histamine ligation (OHIS) or exclusive primary amine ligation (OPD) in yields
greater than 80% by redox titrations. The facile oxidation of primary amines by OTMPD is
not competitive with the fast ligand exchange (ca. 10 min) at −125 °C, allowing respectable
yields of OPD and OHIS.
The displacement of TMPD by these ligands clearly indicates a greater thermodynamic
stability of a O species with primary rather than tertiary amines, a trend that correlates to
DFT calculations [21]. These calculated structures clearly display shorter Cu(III)-N
distances to primary amines than to tertiary amines by ca. 0.05 Å. The one primary amine
J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.
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Cu(III)-N distance, crystallographically characterized at 1.9 Å, is even shorter than those
predicted by DFT calculations [85]. The primary amines, though less basic than tertiary
amines in the gas phase, are stronger donors to the compact Cu(III) centers, as their lesser
steric demands allow closer proximity and greater orbital overlap. Indeed, the O species with
primary amine ligation have LMCT bands that are blue-shifted relative to the tertiary
amines. DFT calculations show the acceptor orbital is antibonding with respect to the Cu-N
bonds; stronger Cu-N bonding should increase the optical transition energy, as observed
experimentally [21]. More remarkable is that ligation from an imidazole is more
thermodynamically stabilizing than from a primary amine for O species. From ligand
exchange reactions, HIS is capable of ligand exchange with OPD to produce OHIS with a
corresponding blue-shift of the LMCT band (378 to 363 nm) [22]. DFT calculations support
an even shorter imidazole Cu(III)-N distance, and time-dependent DFT optical predictions
correlate with the observed optical blue-shifting. These simple ligand exchange reactions
provide the unanticipated result that imidazole ligation best stabilizes a O species of all
neutral nitrogenous ligands examined to date.

Author Manuscript

Despite the greater thermodynamic stability of OPD compared to OTMPD, the former
activates the weak C-H bond of AcrH2 and the latter does not. Isodesmic DFT reactions
suggest that OPD is a stronger hydrogen-atom acceptor than OTMPD, assuming that the
hydrogen-atom reduced product is a Cu(III)Cu(II)-oxide-hydroxide species. On a
thermodynamic basis, OPD should be a faster hydrogen-atom abstracting agent compared to
OTMPD for externally added substrates, which is observed experimentally. Additionally, this
reactivity trend is consistent with greater substrate accessibility to the OPD Cu2O2 core.
Using CHD as a weak C-H atom substrate, the lowest energy pathway calculated by DFT is
along the O-O vector (Fig. 5). N-alkylation impedes this pathway, consistent with the 10fold slower reactivity observed from the O species generated with the more sterically
demanding N,N’-dimethylpropylenediamine with AcrH2 [21].

Monooxygenase Reactivity of O Species
While exogenous oxidase reactivity involving either an ETPT or PCET pathway is amply
demonstrated in the literature for O species, exogenous monooxygenase reactivity has been
demonstrated only for phenolate hydroxylation in a limited number of cases in a
homogeneous solution. By contrast, a heterogenized, discrete O species on nanoparticles are
also known to catalytically oxidize toluene to benzyl alcohol and benzaldehyde at elevated
temperatures using O2 as the oxidant [86]. In all cases, facile substrate accessibility to the
Cu2O2 core is possible [25,28,40,87].

Author Manuscript

In the case of phenolate hydroxylation, initial axial approach of a phenolate to a copper
center followed by rapid rearrangement into an equatorial position of the O core allows for
an inner-sphere hydroxylation to occur [18]. This mechanistic postulate is different from that
generally accepted for Tyrosinase enzymes (Ty), which are proposed to operate through a
side-on Cu(II) peroxide active oxidant (vide infra) [88,89].
Active oxidant identification is a difficult task given the possibility of multiple Cu-O2
structural types existing in facile equilibria. An informative example that showcases these
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intricacies is found in the work of the Suzuki group that observes epoxidation of styrene and
hydroxylation of tetrahydrofuran (THF) at −80 °C by a spectroscopically characterized SP
species [64]. 18O2 experiments confirm the source of the oxygen-atom for the epoxidation,
and the large H(D) KIE of 50 for THF hydroxylation support a rate limiting C-H activation.
Subsequent reactivity studies report not only exogenous phenolate hydroxylation but also CH activation with a wide range of C-H substrates including CHD, fluorene, and toluene. As
this latter reactivity is generally associated with a O rather than a SP species [90], the
authors did not exclude the possible role of a O isomer in these oxidations.

Author Manuscript

A clearer example of step-by-step hydroxylation of an exogenous phenolate by a O species
is the reactivity reported by the Costas group in 2008 [40]. Oxygenation of their
binucleating, Cu(I) polydentate amine complex at −80 °C yields the characteristic optical
and rR spectroscopic features of a O species. Addition of 1.5 equivalents of exogenous
phenolate forms a new intermediate species, A (Fig. 6a), with spectroscopic features similar
to the parent O species, yet with new visible absorption features suggestive of direct
phenolate ligation. This complex thermally decays by a first order process to form catechol
products through an electrophilic oxidation mechanism, evidenced by slower reactivity of
electron deficient phenolates. The simplest interpretation of this data is that a Cu(III) O
species is capable of stoichiometric electrophilic hydroxylation through an inner-sphere
mechanism.

Author Manuscript

Support for a O species acting as the active oxidant for exogenous phenolate hydroxylation
was proposed initially in 2005 starting from a side-on peroxide species, SPDBED, using the
sterically demanding, bidentate N,N’-di-tert-butylethylenediamine (DBED) ligand [18].
While SPDBED hydroxylates added phenolates in high yields relative to oxidant at −80 °C,
no oxidation intermediate is observed. Cooling the reacting mixture to −125 °C stabilizes a
transient intermediate, ADBED, with a 18O2-sensitive stretch at 590 cm−1, a 2.8 Å Cu-Cu
distance, and an intense LMCT band at 418 nm, all fully consistent with a Cu(III)2O2 bisoxide core (Fig. 6b). Additional visible absorptions are assigned as equatorially ligated
phenolate to copper LMCTs through comparative rR studies with 16O and 18O substituted
phenolates, features similar to those reported by Costas et al. (vide supra). ADBED undergoes
first-order decay at −125 °C to produce hydroxylated products with the oxygen-atom derived
from O2. A Hammett ρ-value of −2.2 and an inverse deuterium KIE for the oxidized orthocarbon support an electrophilic oxidation mechanism. The simplest interpretation of these
results is that SPDBED oxidizes phenolates through the intermediacy of a O species that
forms as a result of phenolate binding to the initial SP species.

Author Manuscript

More recent results have created SP species with exclusive imidazole ligation that exhibit a
similar type of SP to O isomerization triggered by phenolate ligation, followed by a firstorder decay with associated phenolate hydroxylation. In 2012 the self-assembly of SP
complexes from 6 monodentate imidazoles, Cu(I), and O2 in near quantitative yields was
reported, albeit the imidazoles required a non-hydrogen substituent adjacent to the ligating
imidazole nitrogen atom, Cu-Nπ ligation (Nπ ≡ Nδ), to be contrasted with the less
sterically demanding Nτ ligation observed exclusively in oxygenated Ty (oxyTy) and oxyHc
[37,88,92] (Fig. 7). These SP complexes hydroxylate electron deficient phenolates to
catechol products without any intermediate detection at −125 °C, and cooling to −145 °C
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only slows this hydroxylation reactivity. In 2016, the biologically-relevant Nτ ligation in
synthetic SP complexes became possible by working at −145 °C; 1-methylimidazole
(SP1MeImd), 4-methylimidazole (SP4MeImd), and imidazole (SPNHImd) complexes are now
characterized [39]. The remote positioning of each imidazole substituent in SP4MeImd and
SP1MeImd results in much more exposed Cu O SP cores. Indeed, SP1MeImd reacts with
2 2
exogenous, electron-deficient phenolates at −145 °C to generate an intermediate, A1MeImd,
with a similar optical spectrum to ADBED, which thermally decomposes to form catechols
(Fig. 6c). The Cu K-edge XAS of A1MeImd reveals a pre-edge feature and a short Cu-Cu
distance (ca. 2.8 Å), both consistent with a O species. The chemical precedence of a Cu(III)
species in a ligand environment remarkably similar to oxyTy suggests that there is no
chemical reason, thermodynamic or kinetic, to exclude Cu(III) from discussions of
biological redox processes.
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Other characterized O species with amine, imine, and hybrid guanidine/amine ligands
exhibit similar stoichiometric electrophilic hydroxylation reactivity with added phenolates,
albeit without detection of an A-like intermediate species (Fig. 6d & 6e). Phenolate
hydroxylation by a TP species has also been proposed using an asymmetric, hexadentate
ligand (Fig. 6f), a reactivity behavior not consistent with its general oxidative tendencies
[38]. Motivated by a measureable O ↔ TP equilibrium, the TP phenolate reactivity is
suggested now to operate through a O species [28]. Chemical precedence that Cu(III) O
species are good electrophilic hydroxylation reagents is now firmly established, yet with
only a single example of biological nitrogenous ligation, the relationship to the active
oxidant in Ty is still tenuous.
Trinuclear

Author Manuscript

The highest nuclearity synthetic cluster known to form directly from the reaction of Cu(I)
and O2 is the trinuclear T cluster with a single Cu(III) center. These synthetic clusters are
much less prevalent than O species. In part, this dearth is due to the more stringent
constraints of formation of the extremely compact T clusters, coupled with greater detection
difficulties of their higher energy and lower intensity optical features compared to other CuO2 species.

Author Manuscript

The disclosure of a T cluster in 1996 by the Stack group resulted from the oxygenation of
[(TMCD)Cu(MeCN)]+ (TMCD = (1R,2R)-tetramethylcyclohexanediamine) at −80 °C. The
3:1 Cu:O2 stoichiometry by manometry and the unique optical spectrum defined a new
structural type, which was confirmed by X-ray diffraction [17]. The metrical parameters of
the two-fold symmetric, tricationic L3Cu3O2 cluster clearly support a valence-localized
Cu(III)Cu(II)Cu(II) bis-μ3-oxide cluster. Each copper center maintains a planar geometry,
with two ligands from the diamine and two from the oxide ligands. The unique Cu site has
shorter Cu-O bonds (ca. 1.8 Å) than the symmetric Cu sites (ca. 2.0 Å), indicative of a
higher oxidation state. Ferromagnetic coupling of two Cu(II) centers, dictated by the acute
Cu(II)-O-Cu(II) angle, leads to a paramagnetic, triplet ground state. While EXAFS modeling
corroborate the metrical parameters of the X-ray structure, the more intense Cu(II) pre-edge
feature at 8979 eV masks any potential lower intensity Cu(III) feature at 8981 eV [31,32]. A

J Biol Inorg Chem. Author manuscript; available in PMC 2018 June 21.

Keown et al.

Page 12

Author Manuscript

limited number of other T complexes formed with non-sterically demanding, bidentate
ligation are known, primarily characterized through their optical spectra [42,43,93,94].
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Reactivity from T clusters remains limited. Generally, T clusters react with weak hydrogenatom donors such as phenols, catechols, and thiols similar to O species, except that the
reactivity has a 1:1 rather than a 2:1 stoichiometry. Redox-titrations indicate reactivity with
ferrocene, but not with acetylferrocene, in line with a mild one-electron oxidant [17,23,93].
Similar to the O species, T clusters exhibit thermal decomposition through ligand Ndealkylation, albeit at much higher temperatures suggesting a more stable complex [44]. The
TTMCD cluster decays at −40 °C to produce formaldehyde and dealkylated ligand with a
measured H(D) KIE of 8 supporting C-H activation as the rate limiting step. Oxygen-atom
transfer to PPh3 is also possible, albeit performed at a higher temperature than with O
species and presumably associated with a Cu(I) formation. Recently, trinuclear Cu clusters
formed with a trinucleating ligand were reported by the Chan group to effect catalytic
hydroxylation of hydrocarbon substrates including methane, using O2 and a sacrificial
reductant. More productive hydroxylation reactivity is found using H2O2 as the oxidant in
both homogeneous and heterogenized solutions [95,96]. The active oxidant is proposed as a
localized valence Cu(III)Cu(II)Cu(II) mono-oxide cluster, as opposed to the μ2-oxide of the
T clusters.

Author Manuscript

Recently, histamine ligated Cu(I) complexes were reported to react with O2 to yield
trinuclear T clusters as the thermodynamic product, the first example of the direct formation
of a Cu(III)-containing cluster from Cu(I) and O2 using a biologically relevant histamine
chelate [23]. By modification of reaction conditions, non-equilibrating mixtures of O and T
clusters could be formed from the same Cu(I)-histamine precursor. Formation kinetics
suggest that the low energy pathway to the trinuclear T species does not involve the reaction
of a Cu(I) species with a O species initially proposed [42], but is better understood to occur
through the intermediacy of an unobserved 2:1 species, presumed to be a SP species (Fig. 8).
The ability to form both T and O species with the same bidentate ligand also allows for a
direct comparison of reactivity between the two cluster types. The reaction of each species
with ascorbic acid as a hydrogen-atom donor shows a stark difference: the T clusters
perform the hydrogen-atom abstraction 106 times slower than the corresponding O species at
parity of ligand. As DFT calculations suggest that the T and O clusters should have
comparable hydrogen-atom affinities, the observed anemic reactivity of the T cluster is
attributed to its limited accessibility, given that influence of steric demands from ligand
substituents on reactivity is known in other Cu-O2 species [22].

Author Manuscript

Synthetic and Biological Worlds
Synthetic systems have certain advantages over biological systems in that working with
simpler ligation reduces characterization complexity, along with the potential of working at
lower temperatures in aprotic solvents to trap intermediates in chemical transformations.
Low temperatures not only attenuate entropic costs of assembly, but also raise effective
barriers to deleterious decay pathways [84]. In effect, one can consider low temperatures and
aprotic polar solvents as surrogates for the protein matrix [37,84], especially considering the
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dielectric inside of a protein matrix is far closer to that of an organic solvent than water
[97,98]. As such, a synergy exists between synthetic Cu-O2 chemistry and chemistry of
biological systems; that gleaned from one is generally applicable to the other, assuming a
limited number of thermodynamically stable Cu-O2 structural types exist. While no enzymes
have been observed to contain Cu(III), several enzymes have been postulated at some point
to use a Cu(III) species for oxidative function [18,99–101].
Oxygenases vs Oxidases

Author Manuscript

Copper enzymes that directly activate O2 can generally be separated into two groups based
on reactivity: monooxygenases and oxidases. Monooxygenases (i.e., dopamine-βmonooxygenase (DBM), peptidylglycine-α-hydroxylating monooxygenase (PHM), lytic
polysaccharide monooxygenases (LPM), Ty, and particulate methane monooxygenase
(pMMO)) are a class of enzyme that hydroxylate organic molecules [4]. In this reaction,
dioxygen is reduced to one equivalent of H2O, and the other oxygen atom is inserted into the
C-H bond of an organic substrate. Oxidases (i.e., galactose oxidase (GO), glyoxal oxidase
(GLOX), amine oxidase (AO), lysyl oxidase (LO), cytochrome c oxidase, and multicopper
oxidases (MCO)) perform oxidations that are coupled to the reduction of O2 without
incorporation of an oxygen-atom into the product. Depending on the enzyme, O2 can be
reduced to either H2O2 or H2O. These groups can be further divided by nuclearity to allow
for easier categorization.
Mononuclear
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Mononuclear copper sites that directly activate O2 in biology are capable of hydroxylation
reactivity (i.e., DBM, PHM, LPM) and oxidase reactivity (i.e., GO, GLOX, AO, LO) [4].
The reaction of O2 with reduced Cu(I) forms is postulated generally to form an initial ES
species [20,24]. For the monooxygenase enzymes, the presumed neutral Cu(I) coordination
yields a monocationic species that reacts with O2 to generate a non-planar Cu(II) ES species,
crystallographically confirmed for PHM [102,103]. This geometry and hydroxylating
reactivity is not consistent with the synthetic Cu(III) species, MP.
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The oxidases, on the other hand, are proposed to react with O2 through a trigonally ligated
Cu(I) monocationic form with two imidazoles and a ligated phenol to form a 4-coordinate
end-on superoxide Cu(II) species. The superoxide is proposed to abstract the phenolic
hydrogen-atom to form a hydroperoxide ligated to either one of the two valence isomers: a
Cu(II)-phenoxyl radical or a Cu(III)-phenolate species. Assuming the former as a strongly
antiferromagnetically coupled species, both valence isomers would be EPR silent, as
observed experimentally [102,104]. Though initially postulated in 1973 as a Cu(III) species
[105], subsequent spectroscopic analyses are more consistent with a Cu(II)-phenoxyl
formulation [106].
Binuclear
Binuclear Cu-O2 sites are also known to act as both monooxygenases (i.e., Ty, Hc, pMMO)
and oxidases (i.e., Ty, CO). Unlike the mononuclear enzymes above, Hc, Ty, and CO are
known to share a similar oxygenated form, a SP species, despite exhibiting different
reactivity. Protein x-ray structures of the oxygenated forms indicate each Cu center is ligated
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in what is best described as a square pyramidal coordination with three imidazole ligands of
histidine residues and two oxygen atoms of the peroxide moiety in a side-on fashion [88,92].
Each imidazole ligates through an Nτ atom with the connecting methylene substituent
positioned remotely, creating an accessible Cu2O2 core. However, as an O2 transport protein,
Hc does not react with exogenous substrates under native conditions, while CO is capable of
catecholase activity (i.e., catechols to quinones), and Ty is capable of both hydroxylase (i.e.,
phenols to catechols) and catecholase reactivity [89]. The difference in reactivity between all
these proteins is attributed largely to variation in substrate access to the Cu2O2 core,
evidenced by Hc showing slow monooxygenase reactivity under mildly denaturing
conditions [107,108]. Extensive reactivity and spectroscopic studies on SP-containing
enzymes and model systems suggest that if Cu(III) is operative in any of these binuclear
copper enzymes, it would be involved in the monooxygenase reactivity, primarily exhibited
by Ty.
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Ty are found in all aerobic life forms and are responsible for pigment biosynthesis through
regioselective tyrosine hydroxylation to a catechol. Subsequent catechol oxidation to a
quinone yields the pigment polymer precursor. While the products of Ty reactivity are well
defined, the intimate details of the hydroxylation are far from complete [109–111]. The Itoh
group have shown that the Ty hydroxylation activity can be decoupled from the catecholase
reactivity under borate buffer conditions, where the catechol is trapped as a borate ester,
consistent with catechol release from the binuclear site [61]. Under these conditions, the
rate-limiting step of the hydroxylation reaction is slowed by electron deficient substrates
(Hammett ρ = −2.4), in line with an electrophilic oxidation mechanism. The KIE of 1.1 for
mushroom Ty with deuterium substitution on the oxidized carbon of the phenol suggests
that the C-H(D) bond cleavage is not rate limiting [61,112].

Author Manuscript
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The generally accepted hydroxylation mechanism of Ty from these and other investigations
are deprotonation of the exogenous phenol by an active-site base, inner-sphere copper
coordination by the phenolate, electrophilic peroxide attack on the aromatic π-system,
followed by proton rearrangement to yield a μ-hydroxo-μ-catecholato intermediate [113].
Protonation of the catecholate releases catechol, generating a dicopper(II)-μ-hydroxo
complex that can further react with the released catechol to produce quinone [89]. While no
Cu(III) intermediate has been detected spectroscopically in biology, substantial synthetic
experimental evidence support Cu(III)-containing O species as chemically competent to
perform phenolate hydroxylation with reaction hallmarks similar to those of Ty. An
alternative mechanism to that generally accepted for Ty is that peroxide bond cleavage
occurs prior to formation of the C-O bond, which would make the O species the active
oxidant [18,39,40] (Fig. 9).
The remaining binuclear enzyme capable of monooxygenase reactivity is pMMO, which
has a unique proposed active site. Its structure was unknown until structural and reactivity
studies supported a binuclear Cu active site as the site oxidation. pMMO mediates the
remarkable transformation of methane to methanol in methanotrophic bacteria under
ambient conditions. X-ray crystallographic and XAS investigations by the Rosenzweig
group identify an asymmetric binuclear copper site, in which one copper is coordinated by
two imidazole groups of histidine residues and the other is chelated by an imidazole and
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primary amine of an N-terminal histidine, termed a histidine brace [114]. The resting state of
the enzyme is a mixed-valence Cu(I)-Cu(II) state from XAS and EPR. However, the active
oxidant formed with O2 is unknown currently [115,116].
In 2005, the first crystal structure of bacterial pMMO at 2.8 Å resolution revealed three
metal sites: a Zn site, a mononuclear Cu site, and an asymmetric binuclear Cu site as
described above [114]. Cu K-edge EXAFS modeling show a short Cu-Cu vector (ca. 2.6 Å),
consistent with the crystal structure and supporting the postulate of a binuclear site. The
geometry at each Cu atom in this binuclear site is nearly planar. The bidentate, planar,
nitrogenous ligation and short Cu-Cu distance better matches the geometry and coordination
preference of a Cu(III) O species than that of a Cu(II) SP species.
Trinuclear
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The trinuclear Cu-O2 enzymes (i.e., laccase, ascorbate oxidase, Fet3p), generally referred to
as MCO, function as oxidases removing weakly reducing electrons from substrates and
reducing O2 by four electrons to water. The fungal laccases are remarkable for their small
overpotential (ca. 100 mV) in the reduction of O2 [117,118]. The structure of the trinuclear
sites are conserved largely across all MCO with the reduction site of O2 possessing three Cu
centers within 4.5 Å [119,120], and a blue copper ET site 12 Å distant. The copper sites of
the fully reduced trinuclear cluster are ligated differentially: two have three imidazole
ligands while the other has two imidazoles and a water or hydroxide; seven of the eight
imidazole ligands are Nτ ligated. The crystallographic data from the Sakurai group on a
small MCO mutant show that oxygenation of a reduced crystal yields a tri-Cu μ3-oxide-μ2hydroxide species as the first and only intermediate, which upon further x-ray exposure
degrades to the fully reduced enzyme [121]. The connectivity and metrical parameters are
consistent with a paramagnetic Cu(II)Cu(II)Cu(II) μ3-oxide-μ2-hydroxide intermediate, or
native intermediate, determined from extensive spectroscopic investigations by the Solomon
group [122]. Spectroscopic investigations of several different MCO lacking their blue
copper sites, including several from the Sakurai group, detect two intermediates, the first as
a diamagnetic species [123–125] and the second as the native intermediate. The first
intermediate is postulated by the Solomon group to be a Cu(I)Cu(II)Cu(II) peroxide species,
yet no direct spectroscopic evidence of a Cu(I) center exists [121] and no 18O sensitive rR
vibrational features in the 600–1200 cm−1 range are observed by excitation into its visible
absorptions [121,123,126]. An alternative postulate that may merge the spectroscopic and xray data is the inclusion of Cu(III) into the discussion.
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Conclusions
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Our knowledge of Cu-O2 chemistry over the past decades has increased rapidly since the
discovery of Cu activating O2 in hemocyanin in 1878 [127,128]. The continued development
of technology for the formation and characterization of Cu-O2 species (e.g., cooling baths,
stopped-flow systems, X-ray techniques) has allowed for the understanding of general
reactivity and characteristics of each distinct species. With these advancements comes
clearer insight into the processes that control Cu-O2 complex formation and subsequent
oxidative reactivity. For example, imidazole-ligated Cu(I) species should be considered as
one or two electron reductants in reacting with O2 if a binuclear or trinuclear cluster is
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formed and the redox potential of the resulting species should lie within the biological
window.
The characterization of Cu(III) species that form from Cu(I) and O2 provide important
chemical precedence to define the conditions and ligation environments for stabilization of
this uncommon oxidation state. Defining spectroscopic and reactivity hallmarks whereby the
presence of Cu(III) might be observed or inferred in a biological system is an exciting
prospect. With the synthetic ligation environments moving ever closer to that observed in
biology and knowing the tendency of these system to stabilize Cu(III), ignoring its role in
biology becomes increasingly difficult.
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Multinuclear systems have advantages over mononuclear systems for stabilizing Cu(III) as
multiple Cu sites enable the four electron reduction of O2 to two strongly anionic oxide
ligands. Notably, multiple Cu-O2 complexes perform Ty-like hydroxylation chemistry
through an observable O intermediate [18,25,39,40]. The well-defined, facile SP ↔ O
equilibrium, observed Cu(III)-containing intermediates, and nearly identical kinetic and
thermodynamic reaction parameters (e.g., KIEs, Hammett ρ-values) support the notion of
Cu(III) as an active player in phenol hydroxylation reactivity akin to Ty, a concept first
proposed in 1990 [129]. For these reasons we suggest that the greatest probability of
detection of Cu(III) in a biological system exists in a multinuclear Cu system that activates
O2.
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Fig. 1.

Formation of the eight structurally characterized Cu-O2 species generated in the reaction of
Cu(I) and O2 with mono-, bi-, tri-, and tetradentate ligation (modified from Mirica et al.)
[18].
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Top left: Ligands that stabilize Cu(I) for reaction with O2 to produce Cu(III)-containing O
species exclusively. Top right: Ligands that oxygenate to T species exclusively. Bottom left:
Sufficiently compact ligands allow formation of both O and T species, dependent on their
substituents and reaction conditions. Bottom right: β-diketiminate ligands that produce all
three Cu(III)-containing species (MP, O, and T).
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Optical spectra of a bis-Cu(II) TP (left), bis-Cu(II) SP (middle), and a bis-Cu(III) O species
(right).
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Comparison of Cu(III/II) potentials for Cu(III) complexes with varied donor strength and
overall complex charge. Adapted from Hanss et al. [55].
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Fig. 5.

The lowest energy DFT calculated pathway for C-H bond activation from cyclohexanediene
(CHD) along the O-O vector of OPD [21].
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Fig. 6.
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Cu-O2 complexes known to perform ortho-hydroxylation of exogenous phenolates through a
O active oxidant. Reactions with complexes a, b, and c proceed through an observed,
phenolate-bonded Cu(III) intermediate [18,39,40]. Complexes d, e, and f are proposed to
react in a similar fashion, although no Cu(III) intermediates are detected spectroscopically
[25,28,38,91].
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Fig. 7.

Left: The oxygenated form of Ty and Hc displaying exclusive Nτ imidazole ligation to the
Cu centers [88,92]. Right: The SP species formed from oxygenation of Cu(I) and 1,2dimethylimidazole showing exclusively Nπ imidazole ligation [37].
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Fig. 8.

Proposed formation mechanism of the trinuclear cluster given observed formation kinetics
[23].
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Fig. 9.
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Two potential phenol hydroxylation mechanisms by Ty. Oxygenation to a SP species,
followed by phenolate ligation with imidazole dissociation creates Int1. The generally
accepted biological mechanism involves a rate limiting concerted C-O bond formation with
C-H bond cleavage to Int2. Alternatively, phenolate rearrangement could trigger O-O bond
cleavage, followed by a rate limiting C-H insertion to Int2.
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